Mast cell leukemia surgery

Mast cell leukemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Mast cell leukemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Mast cell leukemia surgery On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Mast cell leukemia surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Mast cell leukemia surgery
CDC on Mast cell leukemia surgery
Mast cell leukemia surgery in the news
Blogs on Mast cell leukemia surgery
Directions to Hospitals Treating Mast cell leukemia
Risk calculators and risk factors for Mast cell leukemia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy, or bone marrow transplantation may be required in certain cases.

Surgery

The predominant therapy for mast cell leukemia is immunochemotherapy. Surgical management, such as splenectomy, or bone marrow transplantation may be required in certain cases.